Choice can get this wrong — tell us if something's off.
1–10 of 15
Political spendingConfirmed
Pfizer funneled between $500,000 and $1 million to Trump’s 2025 inaugural committee
Tellingly, the industry's lobbying efforts have extended to handouts of raw cash: PhRMA, Pfizer, Bayer, Merck, Eli Lilly, and Abbott Labs each funneled between $500,000 and $1 million to Trump’s 2025 inaugural committee, a plain attempt to curry favor with an administration that is widely perceived as being particularly susceptible to corporate gifts.
Tellingly, the industry's lobbying efforts have extended to handouts of raw cash: PhRMA, Pfizer, Bayer, Merck, Eli Lilly, and Abbott Labs each funneled between $500,000 and $1 million to Trump’s 2025 inaugural committee, a plain attempt to curry favor with an administration that is widely perceived as being particularly susceptible to corporate gifts.
Political spendingConfirmed
Pfizer gives $1 million to Trump's inaugural committee
Pfizer gave $1 million to the inaugural committee for Trump's swearing-in events.
Pfizer, Dow Chemical and Bank of America gave $1 million apiece to the inaugural committee, which raised private funds for the balls, receptions, parade and other events celebrating Trump’s Jan. 20 swearing-in.
Israel & PalestineConfirmed
Pfizer commits to match employee donations for humanitarian aid
Pfizer committed to supporting several key organizations providing emergency assistance in the region and matching employee donations.
Bourla committed Pfizer to supporting “several key organizations that are providing critical emergency assistance in the region” and to matching employee donations.
Health policyConfirmed
Pfizer executives suggest softer drug price cuts
Pfizer executives indicate prescribed drug price cuts will not be as steep as initially feared.
The comments from executives of companies including Pfizer, Bristol Myers Squibb, Johnson & Johnson and AbbVie suggest the price cuts won’t be as steep as many in the industry initially feared.
ManufacturingConfirmed
Pfizer expands COVID-19 pill production
Pfizer expands production of COVID-19 treatment pill at Portage facility, creating 250 jobs.
Pfizer, Merck, Eli Lilly and other drug giants are spending record amounts on lobbying as they fight the Trump administration on vaccine policies and more.
Elections & votingConfirmed
Pfizer suspends donations to election objectors
Pfizer pledged to immediately suspend donations to election objectors in January.
Besides committing to lowering costs, Trump said, Pfizer agreed to spend $70 billion in domestic manufacturing facilities, becoming the latest in a string of major drugmakers to announce plans to build production in the United States.
Wages & economic policyConfirmed
Pfizer lobbies federal agencies
Pfizer engages in federal lobbying activities consistent with disclosed compliance requirements.
Reporting and Compliance Features Federal Lobbying • Pfizer’s disclosures and lobbying activities comply with the Honest Leadership and Open Government Act of 2007.
Health policyConfirmed
Albert Bourla stated that his type is not recommended to take the Covid-19 vaccine
An extract from a TV interview with Pfizer's chief executive Albert Bourla is being shared online alongside the claim that the head of the pharmaceutical giant refused to take the Covid-19 vaccine manufactured by his company because “my type is not recommended”.
An extract from a TV interview with Pfizer's chief executive Albert Bourla is being shared online alongside the claim that the head of the pharmaceutical giant refused to take the Covid-19 vaccine manufactured by his company because “my type is not recommended”.
AAP FACTCHECK - Claims that Pfizer chief executive Albert Bourla said in a live television interview that COVID-19 vaccinations are "quite dangerous" are being spread online - although he never said it.